Global Medical Footwear Market Overview:
Medical Footwear is medical device used in the conservative treatment of foot and lower limb path mechanics. These footwear are manufactured using custom fabricated or prefabricated device that are based on a medical prescription on containing the specific design characteristics as recognized by the medical practitioner. According to a secondary source, in 2019 about 77% of Americans have encountered foot disorders and related issues. Moreover, as per 2018 guideline by Diabetic Foot Australia, it was demonstrated that specific footwear interventions prevent diabetic foot ulcers. Increasing consumption of medical footwear from aged population is driving the market size. Some of the players profiled in the study are DARCO International, Inc. (United States), DJO, LLC (Dr.Comfort) (United States), Gravity Defyer Corp (United States), Drew Shoe (United States), Horng Shin Footwear Co. (Vietam), Aetrex Worldwide, Inc. (United States), Dr. Foot Inc. (Canada), OrthoFeet (United States), Podartis srl (Italy), Dr. Zen, Inc. (United States), Duna srl (Italy), Mephisto (United States), New Balance (United States) and Apex Foot Health, Inc. (United States). According to Market Analyst at AMA, the Global Medical Footwear market may see a growth rate of 6.01%
On the basis of geography, the market of Medical Footwear has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Footwear Material, the sub-segment i.e. Leather will boost the Medical Footwear market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Pricing, the sub-segment i.e. Upto USD 50 will boost the Medical Footwear market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Sales Channel, the sub-segment i.e. Online will boost the Medical Footwear market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Men will boost the Medical Footwear market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Growth Drivers
- Growing Number Of Foot-Related Issues
- Increasing Cases Of Diabetes
- Increasing Consumption from Aged Population
Influencing Trend
- Rising Use of Insoles in Causal Footwear
Restraints
Opportunities
- Growth Of The E-Commerce Industry
- Increasing technological innovation and product launches
Challenges
- Availability of Counterfeit Products
Key Market Developments:
In September 2019, Baretraps launched comfortable shoes with Posture+ technology that help the wearer to correct the posture and reduce strain and pressure on knees, toes, and ankle.
Target Audience:
New Entrants/Investors, Analysts and Strategic Business Planners, Medical Footwear Manufacturer, Raw Material Suppliers, Dealers, Suppliers, Traders, and Distributors, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End Users
Major Objectives Focused through this Study
To define, describe, and forecast the Global Medical Footwear market on the basis of product [Shoes & Boots, Sandals and Others {Slippers, Flip-flops, Insoles}] , application [Diabetic Shoes, Arthritis Shoes, Bunions & Hallux Valgus Shoes, Flat Feet Shoes and Others], key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Medical Footwear market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Medical Footwear industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are
.** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Medical Footwear market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.